Early detection of cognitive impairment in relapsing-remitting multiple sclerosis: Functional-anatomical correlations and longitudinal follow-up;Troubles cognitifs et sclérose en plaques rémittente: Intérêt de leur détection précoce

Revue Neurologique

Volumn 162, Issue 12, 2006, Pages 1221-1231

  Bensa, C ^a   Bertogliati, C ^a   Chanalet, S ^a   Malandain, G ^b   Bedoucha, P ^a   Lebrun, C ^a  

^a PASTEUR HOSPITAL   (France)

^b Inst Natl de Recherche en   (France)

Author keywords

Anatomofunctional correlations; Early detection; Longitudinal follow up; Mild Cognitive Impairment; MRI; Relapsing remitting multiple sclerosis

Indexed keywords

3,4 DIAMINOPYRIDINE; AMANTADINE; ANTIDEPRESSANT AGENT; AZATHIOPRINE; BETA INTERFERON; CARNITINE; COPOLYMER; CYCLOPHOSPHAMIDE; GADOLINIUM; IMMUNOSUPPRESSIVE AGENT; MITOXANTRONE; MODAFINIL; PIRACETAM; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; ATTENTION DISTURBANCE; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; DIAGNOSTIC IMAGING; EXPANDED DISABILITY STATUS SCALE; FATIGUE; FEMALE; FOLLOW UP; HUMAN; HUMAN RELATION; MALE; MEMORY; MEMORY DISORDER; MOTOR PERFORMANCE; MULTIPLE SCLEROSIS; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; STATISTICAL ANALYSIS; TASK PERFORMANCE;

EID: 33845796080     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0035-3787(06)75135-9     Document Type: Article

References (82)

1. ACHIRON A, BARAK Y. (2003). Cognitive impairment in probable multiple sclerosis. J Neurol Neurosurg Psychiatry, 74: 443-446.
2. AMATO M, PONZIANI G, PRACUCCI G, BRACCO L, SIRACUSA G, AMADUCCI L. (1995). Cognitive impairment in early-onset multiple sclerosis. Pattern, predictors, and impact on everyday life in a 4-year follow-up. Arch Neurol, 52: 168-172.
3. AMATO M, PONZIANI G, SIRACUSA G, SORBI S. (2001). Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 years. Arch Neurol, 58: 1602-1606.
4. AMATO MP, TROIANO M, GORETTI B et al. (2004). Begnin Multiple Sclerosis beyond Expanded Disability Status Scale: A Thorough Investigation on cognitive, Psychological and social aspects. Neurology (American Academy of Neurology. San Francisco).
5. ARCHIBALD CJ, WEI X, SCOTT JN et al. (2004). Posterior fossa lesion volume and slowed information processing in multiple sclerosis. Brain, 127: 1526-1534.
6. ARNETT PA, HIGGINSON CI, VOSS WD, BENDER WI, WURST JM, TIPPIN JM. (1999). Depression in multiple sclerosis: relation to working memory capacity. Neuropsychology, 13: 546-556.
7. BARAK Y, ACHIRON A. (2002). Effect of interferon-beta-1b on cognitive functions in multiple sclerosis. Eur Neurol, 47: 11-14.
8. BEATTY WW, GOODKIN DE, MONSON N. (1988). Anterograde and retrograde amnesia in patients with chronic progressive multiple sclerosis. Arch Neurol, 45: 611.
9. BEATTY WW. (1993). Cognitive and emotional disturbances in multiple sclerosis. Behavioral Neurology, 11: 189-204.
10. BEATTY WW, GOODKIN DE. (1990). Screening for cognitive impairment in multiple sclerosis. An evaluation of the Mini-Mental State Examination. Arch Neurol, 47: 297-301.
11. BEATTY WW, GOODKIN DE, HERTSGAARD D, MONSON N. (1990b). Clinical and demographic predictors of cognitive performance in multiple sclerosis. Do diagnostic type, disease duration, and disability matter? Arch Neurol, 47: 305-308.
12. BEATTY WW, PAUL RH, WILBANKS SL, HAMES KA, BLANCO CR, GOODKIN DE. (1995). Identifying multiple sclerosis patients with mild or global cognitive impairment using the Screening Examination for Cognitive Impairment (SEFCI). Neurology, 45: 718-723.
13. BENEDICT RH, FISCHER JS, ARCHIBALD CJ et al. (2002). Minimal neuropsychological assessment of MS patients: a consensus approach. Clin Neuropsychol, 16: 381-397.
14. BERGIN. (1957). Rapidly progressing dementia in disseminated sclerosis. J Neurol, Neurosurg, and Psychiatry, 20: 285-292.
15. BROWNELL B, HUGHES JT. (1962). The distribution of plaques in the cerebrum in multiple sclerosis. J Neurol, Neurosurg, and Psychiatry, 25: 315-320.
16. CALLANAN MM, LOGSDAIL SJ, RON MA, WARRINGTON EK. (1989). Cognitive impairment in patients with clinically isolated lesions of the type seen in multiple sclerosis. A psychometric and MRI study. Brain, 112: 361-374.
17. CHRISTODOULOU C, KRUPP LB, LIANG Z et al. (2003). Cognitive performance and MR markers of cerebral injury in cognitively impaired MS patients. Neurology, 60: 1793-1798.
18. COMI G, FILIPPI M, MARTINELLI V et al. (1995). Brain MRI correlates of cognitive impairment in primary and secondary progressive multiple sclerosis. J Neurol Sci, 132: 222-227.
19. COMI G, ROVARIS M, FALAUTANO M et al. (1999). A multiparametric MRI study of frontal lobe dementia in multiple sclerosis. J Neurol Sci, 171: 135-144.
20. DE STEFANO N, NARAYANAN S, FRANCIS SJ et al. (2002). Diffuse axonal and tissue injury in patients with multiple sclerosis with low cerebral lesion load and no disability. Arch Neurol, 59: 1565-1571.
21. DELUCA J, BARBIERI-BERGER S, JOHNSON SK. (1994). The nature of memory impairment in multiple sclerosis: Acquisition versus retrieval. J Clin Exp Neuropsychol, 16: 183-189.
22. DUJARDIN K, DONZE AC, HAUTECOEUR P. (1998). Attention impairment in recently diagnosed multiple sclerosis. Eur J Neurol, 5: 61-66.
23. DUJARDIN K, SOCKEEL P, CABARET M, DE SEZE J, VERMERSCH P. (2004). BCcogSEP: a French test battery evaluating cognitive functions in multiple sclerosis. Rev Neurol (Paris), 160: 51-62.
24. FEINSTEIN A, KARTSOUNIS LD, MILLER DH, YOUL BD, RON MA. (1992). Clinically isolated lesions of the type seen in multiple sclerosis: a cognitive, psychiatric, and MRI follow up study. J Neurol Neurosurg Psychiatry, 55: 869-876.
25. FILIPPI M, ALBERONI M, MARTINELLI V et al. (1994). Influence of clinical variables on neuropsychological performance in multiple sclerosis. Eur Neurol, 34: 324-328.
26. FISCHER JS, PRIORE R, JACOBS LD et al. (2000). Neuropsychological effects of interferon beta-1a in relapsing multiple sclerosis. Ann Neurol, 48: 885-892.
27. FOONG J, ROZEWICZ L, DAVIE CA, THOMPSON AJ, MILLER DH, RON MA. (1999). Correlates of executive function in multiple sclerosis: the use of magnetic resonance spectroscopy as an index of focal pathology. J Neuropsychiatry Clin Neurosci, 11: 45-50.
28. FOSSATI P, DEWEER B, RAOUX N, ALLILAIRE JF. (1995). Les troubles de la récupération mnésique : un argument en faveur d'un dysfonctionnement sous-cortico-frontal dans la dépression. L'encéphale, 21 : 295-305.
29. FRANKLIN GM, NELSON LM, FILLEY CM et al. (1989). Cognitive loss in multiple sclerosis: Case reports and review of the literature. Arch Neurol, 46: 162-167.
30. FRIEND KB, RABIN BM, GRONINGER L, DELUTY RH, BEVER C, GRATTAN L. (1999) Language functions in patients with multiple sclerosis. Clin Neuropsychol, 13: 78-94.
31. GADEA M, MARTINEZ-BISBAL MC, MARTI-BONMATI L et al. (2004). Spectroscopic axonal damage of the right locus coeruleus relates to selective attention impairment in early stage relapsing-remitting multiple sclerosis. Brain, 127: 89-98.
32. GRANT I, MC DONALD WI, TRIMBLE MR. (1989). Neuropsychological impairment in early multiple sclerosis. In: Mental disorders and cognitive deficits in Multiple Sclerosis (edited by Jensen K, K. L., Stenager E, and Grant I). London: John Libbey.
33. GREENE YM, TARIOT PN, WISHART H et al. (2000). A 12-week, open trial of donepezil hydrochloride in patients with multiple sclerosis and associated cognitive impairments. J Clin Psychopharmacol, 20: 350-356.
34. GROBER E, BUSCHKE H, CRYSTAL H et al. (1988). Screening for dementia by memory testing. Neurology, 38: 900-903.
35. GRONWALL DMA. (1977). Paced auditory serial-addition task: a mesure of recovery from concussion. Percept Mot Skills, 44: 367-373.
36. HEATON RK, NELSON LM, THOMPSON DS, BURKS JS, FRANKLIN GM. (1985). Neuropsychological findings in relapsing-remitting and chronic-progressive multiple sclerosis. Journal of Consulting and Clinical Psychology, 53: 103-110.
37. JENNEKENS-SCHINKEL A, LABOYRIE PM, LANSER JBK et al. (1990). Cognition in patients with multiple sclerosis after four years. J Neurol Sci, 99: 229-247.
38. KAPLAN ED, GOODGLASS H, WEINTRAUB S. (1983). Boston naming test. Philadelphia.
39. KLONNOF U, CLARK C, OGER J, PATY D, LI D. (1991) Neurological performance in patients with mild multiple sclerosis. J Nervous Mental Dis, 179: 127-131.
40. KRUPP LB, ELKINS LH. (2000). Fatigue and declines in cognitive functioning in multiple sclerosis. Neurology, 55: 934-939.
41. KRUPP LB, CHRISTODOULOU C, MELVILLE P, SCHERL WF, MACALLISTER WS, ELKINS LE. (2004). Affects of Donepezil on memory and cognition in Multiple Sclerosis: Comprehensive Analysis of the AIMS Study. Neurology, 62: 179-180.
42. KUJALA P, PORTIN R, RUUTIAINEN J. (1996). Memory deficits and early cognitive deterioration in MS. Acta Neurol Scand, 93: 329-335.
43. KUJALA P, PORTIN R, RUUTIAINEN J. (1997). The progress of cognitive decline in multiple sclerosis. A controlled 3-year follow-up. Brain, 120: 289-297.
44. KUNKEL A, SCHULZ D, FAISS JH. (2004). Cognition in the early stage of multiple sclerosis. European Neurology Society. (Barcelona).
45. KURTZKE JF. (1983). Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology, 33: 1444-1452.
46. LEMSKY C, CHULUNE G, FERMAN TJ, IVNIK RJ. (1998). Detecting clinically relevant memory changes in elderly patients. J Int Neuropsychol Soc, 4: 53.
47. LYON-CAEN O, JOUVANT R, HAUSER S et al. (1986). Cognitive function in recent-onset demyelinating disease. Arch Neurol, 43: 1138-1141.
48. MARIANI C, FARINA E, CAPPA SF et al. (1991). Neuropsychological assessment in multiple sclerosis: a follow-up study with magnetic resonance imaging. J Neurol, 238: 395-400.
49. MARIE RM, DEFER GL. (2001). Memory and executive functions in multiple sclerosis: preliminary findings with a cognitive battery. Rev Neurol, 157: 402-408.
50. MC DONALD WI, COMPSTON A, EDAN G et al. (2001). Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol, 50: 121-127.
51. PAN JW, ELKINS LE, COYLE PK. (2001). Cognitive dysfunction lateralizes with NAA in multiple sclerosis. Appl Neuropsychol, 8: 155-160.
52. PATTI F, FAILLA G, CIANCIO MR, L'EPISCOPO MR, REGGIO A. (1998). Neuropsychological, neuroradiological and clinical findings in multiple sclerosis. A 3 year follow-up study. Eur J Neurol, 5: 283-286.
53. PELLETIER J, HABIB M, LYON-CAEN O, SALAMON G, PONCET M, KHALIL R. (1993). Functional and magnetic resonance imaging correlates of callosal involvement in multiple sclerosis. Archives of Neurology, 50: 1077-1082.
54. PETERSEN RC, SMITH GE, WARING SC, IVNIK RJ, TANGELOS EG, KOKMEN E. (1999). Mild cognitive impairment: clinical characterization and outcome. Arch Neurol, 56: 303-308.
55. PEYSER JM, EDWARDS KR, POSER CM, FILSKOV SB. (1980). Cognitive function in patients with multiple sclerosis. Arch Neurol, 37: 577-579.
56. PIRAS MR, MAGNANO I, CANU ED et al. (2003). Longitudinal study of cognitive dysfunction in multiple sclerosis: neuropsychological, neuroradiological, and neurophysiological findings. J Neurol Neurosurg Psychiatry, 74: 878-885.
57. PLISKIN NH, HAMER DP, GOLDSTEIN DS et al. (1996). Improved delayed visual reproduction test performance in multiple sclerosis patients receiving interferon beta-1b. Neurology, 47: 1463-1468.
58. POSER CM, PATY DW, SCHEINBERG L et al. (1983). New diagnosis criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol, 13: 227-231.
59. RANJEVA JP, AUDOIN B, DUONG MVA et al. (2004). MR Study of the Influence of Tissue Damage and cortical. Reorganization on PASAT Performance at the Earliest Stage of Multiple Sclerosis. American Academy of Neurology (edited by Neurology). San Francisco.
60. RAO SM, LEO GJ, SAINT AUBIN-FAUBERT P. (1989a). On the nature of memory disturbance in multiple sclerosis. J Clin Exp Neuropsychology, 11: 699-712.
61. RAO SM, LEO GJ, HAUGHTON VM, ST AUBIN-FAUBERT P, BERNARDIN L. (1989b). Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis. Neurology, 39: 161-166.
62. RAO SM, LEO GJ, BERNARDIN L, UNVERZAGT F. (1991a). Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology, 41: 685-691.
63. RAO SM, LEO GJ, ELLINGTON L, NAUERTZ T, BERNARDIN L, UNVERZAGT F. (1991b). Cognitive dysfunction in multiple sclerosis: II. Impact on employment and social functioning. Neurology, 41: 692-696.
64. RAO SM. (1995). Neuropsychology of multiple sclerosis. Current opinion in Neurology, 8: 216-220.
65. REITAN RM. (1958). Validity of the trail making test as an indicator of organic brain damage. Percept Mot Skills, 8: 271-276.
66. ROVARIS M, FILIPPI M, FALAUTANO M et al. (1998). Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis. Neurology, 50: 1601-1608.
67. RUGGIERI RM, PALERMO R, VITELLO G, GENNUSO M, SETTIPANI N, PICCOLI F. (2003). Cognitive impairment in patients suffering from relapsing-remitting multiple sclerosis with EDSS < or = 3.5. Acta Neurol Scand, 108: 323-326.
68. SADOVNICK AD, REMICK RA, ALLEN J, SWARTZ E, YEE IM, EISEN K et al. (1996). Depression and multiple sclerosis. Neurology, 46: 628-632.
69. SIGNORET JL, BONVARLET M, BENOIT N, BOLGERT F, EUSTACHE F, LEGER JM. (1988). Batterie d'estimation des états démentiels ; description et validation. In la maladie d'Alzheimer et ses limites. Congrès de psychiatrie et de neurologie de langue française (edited by Masson). Paris. pp. 265-270.
70. SPERLING RA, GUTTMANN CR, HOHOL MJ et al. (2001). Regional magnetic resonance imaging lesion burden and cognitive function in multiple sclerosis: a longitudinal study. Arch Neurol, 58: 115-121.
71. STROOP JR. (1935). Studies of interference in serial verbal reactions. J Exp Psychol, 18: 643-662.
72. TOURBAH A, BERRY I. (2001). Practical recommendations for MRI in MS. Practical recommendations for MRI in MS. Rev Neurol, 157: 122-125.
73. TUCKER DM, DERRYBERRY D. (1992). Motivated attention: anxiety and the frontal executive functions. Neuropsychiatry Neuropsychol Behav Neurol, 5: 233-252.
74. VAN BUCHEM MA, GROSSMAN RI, ARMSTRONG C et al. (1998). Correlation of volumetric magnetization transfer imaging with clinical data in MS. Neurology, 50: 1609-1617.
75. VAN DEN BURG W, VAN ZOMEREN AH, MINDERHOUD JM, PRANGE AJ, MEIJER NS. (1987). Cognitive impairment in patients with multiple sclerosis and mild physical disability. Arch Neurol, 44: 494-501.
76. VERNAY D, GERBAUD L, CLAVELOU P et al. (2002). Quality of Life for MS patients: reference standards from a large panel of patients. ECTRIMS, Baltimore.
77. WECHSLER D. (1955). Manual for Wechsler adult intelligence scale. New York.
78. WILKEN JA, WALLIN M, SULLIVAN CL et al. (2004). Combination therapy (Provigil° + Avonex) in the treatment of attention problems in patients with relapsing-remitting MS. American Academy of Neurology (San Francisco).
79. WISHART H, SHARPE D. (1997). Neuropsychological aspects of multiple sclerosis: a quantitative review. J Clin Exp Neuropsychol, 19: 810-824.
80. YOUNG AC, SAUNDERS J, PONSFORD JR. (1976). Mental change as an early feature of multiple sclerosis. J Neurol, Neurosurg, and Psychiatry, 39: 1008-1013.
81. ZEPHIR H, DE SÈZE J, DUJARDIN K et al. (2004). Mitoxantrone improves cognitive dysfunctioning of patients in very active multiple sclerosis. European Neurology Society. Barcelona, Spain.
82. ZIVADINOV R, SEPCIC J, NASUELLI D et al. (2001). A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry, 70: 773-780.